Thu, February 1, 2024
Wed, January 31, 2024
Tue, January 30, 2024
Mon, January 29, 2024
Fri, January 26, 2024

Joel Beatty Maintained (BMRN) at Buy with Decreased Target to $104 on, Jan 30th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-104-on-jan-30th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Joel Beatty of Baird, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $127 to $104 on, Jan 30th, 2024.

Joel has made no other calls on BMRN in the last 4 months.



There are 8 other peers that have a rating on BMRN. Out of the 8 peers that are also analyzing BMRN, 2 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Luca Issi of "RBC Capital" Reiterated at Hold and Held Target at $100 on, Tuesday, November 7th, 2023
  • William Pickering of "Bernstein" Upgraded from Sell to Hold and Held Target at $82 on, Monday, October 23rd, 2023


These are the ratings of the 6 analyists that currently disagree with Joel


  • Paul Matteis of "Stifel" Reiterated at Strong Buy and Held Target at $101 on, Thursday, December 21st, 2023
  • Kostas Biliouris of "BMO Capital" Maintained at Buy with Decreased Target to $100 on, Friday, November 3rd, 2023
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $117 on, Thursday, November 2nd, 2023
  • Olivia Brayer of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $100 on, Thursday, November 2nd, 2023
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $115 on, Thursday, November 2nd, 2023
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $111 on, Thursday, November 2nd, 2023